Sarin SK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13(4):353–390

Article  PubMed  Google Scholar 

Choudhury A, et al. Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int. 2017;11(5):461–471

Article  CAS  PubMed  Google Scholar 

Mahmud N, et al. Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis. Hepatology. 2019;69(5):2150–2163

Article  PubMed  Google Scholar 

Lan Y, et al. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2019. Hepatol Commun. 2023;7(2):e0026

Article  PubMed  PubMed Central  Google Scholar 

Chan KE, et al. Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals. J Clin Endocrinol Metab. 2022;107(9):2691–2700

Article  PubMed  Google Scholar 

Liu J, et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol. 2022;20(3):e573–e582

Article  PubMed  Google Scholar 

Orman ES, et al. Trends in characteristics, mortality, and other outcomes of patients with newly diagnosed cirrhosis. JAMA Netw Open. 2019;2(6):e196412

Article  PubMed  PubMed Central  Google Scholar 

Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol. 2016;13(3):131–149

Article  CAS  PubMed  Google Scholar 

Moreau R, et al. EASL clinical practice guidelines on acute-on-chronic liver failure. J Hepatol. 2023;79(2):461–491

Article  Google Scholar 

Sarin SK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the Study of the Liver (APASL) 2014. Hepatol Int. 2014;8(4):453–471

Article  PubMed  Google Scholar 

Choudhury A, et al. Systemic inflammatory response syndrome in acute-on-chronic liver failure: relevance of ‘golden window’: a prospective study. J Gastroenterol Hepatol. 2017;32(12):1989–1997

Article  CAS  PubMed  Google Scholar 

Zaccherini G, Weiss E, Moreau R. Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment. JHEP Reports. 2021;3(1):100176

Article  PubMed  Google Scholar 

Sarin SK, Choudhury A. Acute-on-chronic liver failure. Curr Gastroenterol Rep. 2016;18(12):61

Article  PubMed  Google Scholar 

Chalasani N, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the american association for the study of liver diseases. Hepatology. 2018;67(1):328–357

Article  PubMed  Google Scholar 

Wong VW, et al. Asia-Pacific working party on non-alcoholic fatty liver disease guidelines 2017-part 1: definition, risk factors and assessment. J Gastroenterol Hepatol. 2018;33(1):70–85

Article  PubMed  Google Scholar 

EASL-EASD-EASO,. Clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64(6):1388–1402

Article  Google Scholar 

Siddiqui MS, et al. Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science. Hepatology. 2018;67(5):2001–2012

Article  PubMed  Google Scholar 

Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999-2014.e1

Article  CAS  PubMed  Google Scholar 

Yamamura S, et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 2020;40(12):3018–3030

Article  CAS  PubMed  Google Scholar 

Eslam M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209

Article  PubMed  Google Scholar 

Sepanlou SG, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. The Lancet Gastroenterology & Hepatology. 2020;5(3):245–266

Article  Google Scholar 

Sarin SK, et al. Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol. 2020;5(2):167–228

Article  PubMed  Google Scholar 

Lim GEH, et al. An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin Gastroenterol Hepatol. 2023;21(3):619-629.e7

Article  PubMed  Google Scholar 

Axley P, et al. NASH Is the most rapidly growing etiology for acute-on-chronic liver failure-related hospitalization and disease burden in the united states: a population-based study. Liver Transpl. 2019;25(5):695–705

Article  PubMed  Google Scholar 

Sundaram V, et al. Acute on chronic liver failure from nonalcoholic fatty liver disease: a growing and aging cohort with rising mortality. Hepatology. 2021;73(5):1932–1944

Article  PubMed  Google Scholar 

Selva Rajoo A, et al. Acute-on-chronic liver failure in a multi-ethnic Asian city: a comparison of patients identified by Asia-Pacific association for the study of the liver and european association for the study of the liver definitions. World J Hepatol. 2017;9(28):1133–1140

Article  PubMed  PubMed Central  Google Scholar 

Devarbhavi H, et al. Drug-induced acute-on-chronic liver failure in Asian patients. Am J Gastroenterol. 2019;114(6):929–937

Article  PubMed  Google Scholar 

Duseja A, et al. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF). J Dig Dis. 2013;14(9):484–490

Article  CAS  PubMed  Google Scholar 

Kulkarni S, et al. Acute on chronic liver failure-in-hospital predictors of mortality in ICU. J Clin Exp Hepatol. 2018;8(2):144–155

Article  PubMed  Google Scholar 

Lai RM, et al. Effect of type 2 diabetic mellitus in the prognosis of acute-on-chronic liver failure patients in China. World J Gastroenterol. 2021;27(23):3372–3385

Article  CAS  PubMed  PubMed Central  Google Scholar 

Valantine B, et al. Predictors of early mortality among patients with acute-on-chronic liver failure. JGH Open. 2021;5(6):686–694

Article  PubMed  PubMed Central  Google Scholar 

Gawande A, et al. Acute-on-chronic liver failure: etiology of chronic and acute precipitating factors and their effect on mortality. J Clin Exp Hepatol. 2019;9(6):699–703

Article  PubMed  PubMed Central  Google Scholar 

Amarapurkar D, et al. Acute-on-chronic liver failure: a prospective study to determine the clinical profile, outcome, and factors predicting mortality. Indian J Gastroenterol. 2015;34(3):216–224

Article  PubMed  Google Scholar 

Duseja A, et al. Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure. Liver Int. 2021;41(1):150–157

Article  PubMed  Google Scholar 

Wang NT, et al. Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: systematic review and meta-analysis. J Chin Med Assoc. 2016;79(7):368–374

Article